Revlimid, Imitative of Thalidomide
Lenalidomide with the trade name Revlimid is imitative of thalidomide which was introduced in 2004 and developed by modification of the structural backbone of thalidomide. It was intended as a treatment for multiple myeloma at first while thalidomide is an accepted therapeutic treatment for it.